Quick Answer
CTT PHARMACEUTICAL HOLDINGS, INC. reported Operating Income of $92.2 thousand for fiscal year 2013.
CTT PHARMACEUTICAL HOLDINGS, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2013 | $92.2K | +107.7% |
| 2012 | -$1.19M | -57.7% |
| 2011 | -$757.9K | +63.4% |
| 2010 | -$2.07M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| June 30, 2014 | -$22.3K | +64.3% | +17.9% |
| March 31, 2014 | -$27.2K | +54.9% | -5.7% |
| September 30, 2013 | -$25.7K | +78.3% | +58.8% |
| June 30, 2013 | -$62.5K | +67.3% | -3.7% |
| March 31, 2013 | -$60.3K | +89.7% | +49.1% |
| September 30, 2012 | -$118.5K | -10.3% | +38.1% |
| June 30, 2012 | -$191.5K | +56.2% | +67.1% |
| March 31, 2012 | -$582.8K | -2070.0% | -442.6% |
- CTT PHARMACEUTICAL HOLDINGS, INC. showed an increase of +107.7% in Operating Income compared to the prior fiscal year.
- Over the 2010–2013 period, CTT PHARMACEUTICAL HOLDINGS, INC.’s operating income has grown by 104.5% (from -$2.07 million to $92.2 thousand).
- The most recent figure is from CTT PHARMACEUTICAL HOLDINGS, INC.’s fiscal year 2013 report (Form 10-K), filed with the SEC on February 10, 2014.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: